Skip to main content
Erschienen in: Clinical Rheumatology 7/2015

01.07.2015 | Original Article

Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis

verfasst von: X. Wang, B. Chen, N. Lv, Q. Liu, Aimin Dang

Erschienen in: Clinical Rheumatology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Our study aimed to determine whether proatherogenic lipid profiles exist in patients with active Takayasu arteritis (TA) and assess the relationship between different lipid profiles and disease activity in TA. A total of 132 premenopausal female patients with TA and 100 sex-, age-, and body mass index-matched healthy controls were included in our study. The clinical data were collected in detail from all participants. Patients with active TA had significantly lower levels of apolipoprotein A1 (apoA1) (1.47 ± 0.30 vs. 1.99 ± 0.33 mmol/L, p < 0.001) and lower levels of high-density lipoprotein cholesterol (HDL-C) (1.23 ± 0.33 vs. 1.68 ± 0.38 mmol/L, p < 0.001) than patients with inactive TA. However, they had higher ratios of apolipoprotein B (apoB)/apoA1 (0.74 ± 0.27 vs. 0.48 ± 0.14, p < 0.001) compared with patients with inactive TA. Multiple linear regression analysis demonstrated that the apoB/apoA1 ratio was independently associated with TA activity (β = 0.38, p = 0.04). In addition, multivariate stepwise forward regression analysis showed that the apoB/apoA1 ratio was the major determinant for high-sensitivity C-reactive protein (β = 0.58, p = 0.002). Our findings indicate that patients with active TA had proatherogenic lipid profiles. In addition, the ratio of apoB to apoA1 could be used as a marker for monitoring and targeting patients with TA.
Literatur
1.
Zurück zum Zitat Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu’s disease). Circulation 80:429–437PubMedCrossRef Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu’s disease). Circulation 80:429–437PubMedCrossRef
2.
Zurück zum Zitat Park KC, Kim JH, Yoon SS, Heo SH (2008) Takayasu’s disease presenting with atherothrombotic ischaemic stroke. Neurol Sci 29:363–366PubMedCrossRef Park KC, Kim JH, Yoon SS, Heo SH (2008) Takayasu’s disease presenting with atherothrombotic ischaemic stroke. Neurol Sci 29:363–366PubMedCrossRef
3.
4.
Zurück zum Zitat Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu’s arteritis. Lancet 356:1023–1025PubMedCrossRef Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu’s arteritis. Lancet 356:1023–1025PubMedCrossRef
5.
Zurück zum Zitat Raninen RO, Kupari MM, Hekali PE (2002) Carotid and femoral artery stiffness in Takayasu’s arteritis. An ultrasound study. Sacnd J Rheumatol 31:85–88CrossRef Raninen RO, Kupari MM, Hekali PE (2002) Carotid and femoral artery stiffness in Takayasu’s arteritis. An ultrasound study. Sacnd J Rheumatol 31:85–88CrossRef
6.
Zurück zum Zitat Park SH, Chung JW, Lee JW, Han MH, Park JH (2001) Carotid artery involvement in Takayasu’s arteritis: evaluation of the activity by ultrasonography. J Ultrasound Med 20:371–378PubMed Park SH, Chung JW, Lee JW, Han MH, Park JH (2001) Carotid artery involvement in Takayasu’s arteritis: evaluation of the activity by ultrasonography. J Ultrasound Med 20:371–378PubMed
7.
Zurück zum Zitat de Carvalho JF, Bonfá E, Bezerra MC, Pereira RM (2009) High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clin Rheumatol 28:801–805PubMedCrossRef de Carvalho JF, Bonfá E, Bezerra MC, Pereira RM (2009) High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clin Rheumatol 28:801–805PubMedCrossRef
8.
Zurück zum Zitat Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134PubMedCrossRef Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134PubMedCrossRef
9.
Zurück zum Zitat Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–S163PubMedCrossRef Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–S163PubMedCrossRef
10.
Zurück zum Zitat Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al (1994) Takayasu arteritis. Ann Intern Med 120:919–929PubMedCrossRef Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al (1994) Takayasu arteritis. Ann Intern Med 120:919–929PubMedCrossRef
11.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) JAMA 285:2486–2497CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) JAMA 285:2486–2497CrossRef
12.
Zurück zum Zitat Tani S, Saito Y, Anazawa T, Kawamata H, Furuya S, Takahashi H et al (2011) Low-density lipoprotein cholesterol/apolipoprotein B ratio may be a useful index that differs in statin-treated patients with and without coronary artery disease: a case control study. Int Heart J 52:343–347PubMedCrossRef Tani S, Saito Y, Anazawa T, Kawamata H, Furuya S, Takahashi H et al (2011) Low-density lipoprotein cholesterol/apolipoprotein B ratio may be a useful index that differs in statin-treated patients with and without coronary artery disease: a case control study. Int Heart J 52:343–347PubMedCrossRef
13.
Zurück zum Zitat Kim SW, Jee JH, Kim HJ, Jin SM, Suh S, Bae JC et al (2013) Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol 3:2678–2683CrossRef Kim SW, Jee JH, Kim HJ, Jin SM, Suh S, Bae JC et al (2013) Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol 3:2678–2683CrossRef
14.
Zurück zum Zitat Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J et al (2009) Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J 30:710–717PubMedCentralPubMedCrossRef Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J et al (2009) Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J 30:710–717PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Mattsson N, Magnussen CG, Rönnemaa T, Mallat Z, Benessiano J, Jula A et al (2010) Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study. Arterioscler Thromb Vasc Biol 30:1861–1866PubMedCrossRef Mattsson N, Magnussen CG, Rönnemaa T, Mallat Z, Benessiano J, Jula A et al (2010) Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study. Arterioscler Thromb Vasc Biol 30:1861–1866PubMedCrossRef
16.
Zurück zum Zitat Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR et al (2006) Endothelial lipase is associated with inflammation in humans. J Lipid Res 47:2808–2813PubMedCrossRef Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR et al (2006) Endothelial lipase is associated with inflammation in humans. J Lipid Res 47:2808–2813PubMedCrossRef
17.
Zurück zum Zitat de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E (2004) Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 50:3610–3615PubMedCrossRef de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E (2004) Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 50:3610–3615PubMedCrossRef
18.
Zurück zum Zitat Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR et al (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169–1196PubMedCrossRef Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR et al (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169–1196PubMedCrossRef
19.
Zurück zum Zitat Dullaart RP, Perton F, Kappelle PJ, de Vries R, Sluiter WJ, van Tol A (2010) Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men. Biochim Biophys Acta 1801:84–88PubMedCrossRef Dullaart RP, Perton F, Kappelle PJ, de Vries R, Sluiter WJ, van Tol A (2010) Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men. Biochim Biophys Acta 1801:84–88PubMedCrossRef
20.
Zurück zum Zitat Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C et al (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527–2533PubMedCrossRef Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C et al (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527–2533PubMedCrossRef
21.
Zurück zum Zitat Sniderman AD (2005) Apolipoprotein B versus non-high-density lipoprotein cholesterol—and the winner is…. Circulation 112:3366–3367PubMedCrossRef Sniderman AD (2005) Apolipoprotein B versus non-high-density lipoprotein cholesterol—and the winner is…. Circulation 112:3366–3367PubMedCrossRef
22.
Zurück zum Zitat Faraj M, Messier L, Bastard JP, Tardif A, Godbout A, Prud’homme D et al (2006) Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia 49:1637–1646PubMedCrossRef Faraj M, Messier L, Bastard JP, Tardif A, Godbout A, Prud’homme D et al (2006) Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia 49:1637–1646PubMedCrossRef
23.
Zurück zum Zitat Onat A, Can G, Hergenç G, Yazici M, Karabulut A, Albayrak S (2007) Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes 31:1119–1125CrossRef Onat A, Can G, Hergenç G, Yazici M, Karabulut A, Albayrak S (2007) Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes 31:1119–1125CrossRef
25.
Zurück zum Zitat Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355–1363PubMedCrossRef Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355–1363PubMedCrossRef
26.
Zurück zum Zitat Blum A, Shamburek R (2009) The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 203:325–330PubMedCrossRef Blum A, Shamburek R (2009) The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 203:325–330PubMedCrossRef
Metadaten
Titel
Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis
verfasst von
X. Wang
B. Chen
N. Lv
Q. Liu
Aimin Dang
Publikationsdatum
01.07.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 7/2015
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2819-4

Weitere Artikel der Ausgabe 7/2015

Clinical Rheumatology 7/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.